Season four of A View On has come to a close, and we are looking back at everything it covered.
This season took us across some of the most demanding frontiers in pharmaceutical manufacturing, in conversation with Lonza scientists, our partners, and voices from across the industry. Together they unpacked how medicines are growing more complex and what it takes to make them, from antibody-based therapies and multispecific formats to bioconjugates, mRNA, microbial production, AI-guided development, and a new generation of drug delivery devices.
In this final episode, host Martina Ribar Hestericova draws the threads together, revisiting the ideas that defined the season and offering a first look at what is coming when A View On returns later this year.
The presented information was correct and current at the time of publication.